Atlas Trials

CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis

Clinical trial NCT02647762 · TERMINATED

Trial details

NCT number
NCT02647762
Sponsor
Can-Fite BioPharma
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2017-10-30
Primary completion
2020-11-30
Enrollment
244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.